CSIMarket
 


Amneal Pharmaceuticals Inc   (AMRX)
Other Ticker:  
 

Cumulative Amneal Pharmaceuticals Inc 's Total Debt to Equity for Trailing Twelve Months Period

AMRX's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

AMRX Total Debt to Equity for Trailing Twelve Months Period

(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Equity Growth -89.12 % -20.62 % -12.85 % -66.95 % -49.87 %
Y / Y Total Debt Growth -7.7 % -2.46 % -2.74 % -4.12 % -3.27 %
Total Debt to Equity for Trailing Twelve Months Period 22.11 16.62 15.72 15.31 11.07
Total Ranking # 2144 # 3066 # 3187 # 3269 # 3612
Seq. Equity Growth -87.03 % 2.3 % 11.96 % -26.8 % -5.31 %
Seq. Total Debt Growth -5.92 % -0.28 % -0.47 % -1.15 % -0.58 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2023
On the trailing twelve months basis Despite repayements of liabilities of -5.92% in IV. Quarter, Total Debt to Equity for Trailing Twelve Months Period improved to 22.11, a new company high.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 91 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Amneal Pharmaceuticals Inc . While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
AMRX Charts and Quotes
Total Debt to Equity AMRX in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 92
Sector # 245
S&P 500 # 2149


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
22.11 8.94 3.05
(Dec 31 2023)   (Mar 31 2019)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Total Debt to Equity for Trailing Twelve Months Period
Soligenix inc   28.21 
Amneal Pharmaceuticals Inc   20.71 
Jaguar Health inc   13.14 
Bioxcel Therapeutics Inc   11.87 
Xeris Biopharma Holdings Inc   10.45 
Omeros Corp  7.48 
Avadel Pharmaceuticals Plc  5.20 
Abbvie inc   4.62 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com